Trials / Sponsors / Pieris Pharmaceuticals, Inc.
Pieris Pharmaceuticals, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Cinrebafusp Alfa in Combination With Ramucirumab and Paclitaxel in HER2-High Gastric or GEJ Adenocarcinoma and HER2-positive Gastric Cancer | Phase 2 | 2021-11-01 |
| Completed | PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Bladder Cancer | Phase 1 | 2018-08-21 |
| Completed | PRS-343 in HER2-Positive Solid Tumors HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Bladder Cancer | Phase 1 | 2017-09-13 |